Clinical Trial Update: Progesterone and Resting Energy Expenditure [Phase 4]

View source ↗

Summary

Phase 4 trial update for progesterone related to resting energy expenditure in menopause; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• PROGESTERONE (Progesterone)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Menopause, Progesterone | Phase 4 | Status: TERMINATED